ATE137263T1 - Erhöhung der katalytischen aktivität von ribozymen mit einem benachbartem oligonukleotid als heffer - Google Patents

Erhöhung der katalytischen aktivität von ribozymen mit einem benachbartem oligonukleotid als heffer

Info

Publication number
ATE137263T1
ATE137263T1 AT93904711T AT93904711T ATE137263T1 AT E137263 T1 ATE137263 T1 AT E137263T1 AT 93904711 T AT93904711 T AT 93904711T AT 93904711 T AT93904711 T AT 93904711T AT E137263 T1 ATE137263 T1 AT E137263T1
Authority
AT
Austria
Prior art keywords
increasing
catalytic activity
ribozyme
heffer
ribozymes
Prior art date
Application number
AT93904711T
Other languages
English (en)
Inventor
John Goodchild
Original Assignee
Worcester Found Ex Biology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Worcester Found Ex Biology filed Critical Worcester Found Ex Biology
Application granted granted Critical
Publication of ATE137263T1 publication Critical patent/ATE137263T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • C12N15/1132Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against retroviridae, e.g. HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/11Antisense
    • C12N2310/111Antisense spanning the whole gene, or a large part of it
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/12Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
    • C12N2310/121Hammerhead
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Enzymes And Modification Thereof (AREA)
AT93904711T 1992-02-04 1993-02-04 Erhöhung der katalytischen aktivität von ribozymen mit einem benachbartem oligonukleotid als heffer ATE137263T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US83071392A 1992-02-04 1992-02-04
PCT/US1993/000783 WO1993015194A1 (en) 1992-02-04 1993-02-04 Enhancement of ribozyme catalytic activity by a neighboring facilitator oligonucleotide
CA002106015A CA2106015A1 (en) 1992-02-04 1993-09-13 Ribozymes having 2'-0 substituted nucleotides in the flanking sequences

Publications (1)

Publication Number Publication Date
ATE137263T1 true ATE137263T1 (de) 1996-05-15

Family

ID=25676634

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93904711T ATE137263T1 (de) 1992-02-04 1993-02-04 Erhöhung der katalytischen aktivität von ribozymen mit einem benachbartem oligonukleotid als heffer

Country Status (10)

Country Link
EP (1) EP0625194B1 (de)
JP (1) JPH07508638A (de)
AT (1) ATE137263T1 (de)
AU (1) AU661124B2 (de)
CA (2) CA2117428A1 (de)
DE (1) DE69302369T2 (de)
DK (1) DK0625194T3 (de)
ES (1) ES2085767T3 (de)
GR (1) GR3019911T3 (de)
WO (1) WO1993015194A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3933384A1 (de) * 1989-10-06 1991-04-18 Hoechst Ag Multifunktionelle rna mit selbstprozessierungsaktivitaet, ihre herstellung und ihre verwendung
US5739309A (en) * 1993-07-19 1998-04-14 Gen-Probe Incorporated Enhancement of oligonucleotide inhibition of protein production, cell proliferation and / or multiplication of infectious disease pathogens
KR960704034A (ko) * 1993-07-19 1996-08-31 다니엘 엘. 캐시앙 단백질 생산, 세포 증식 및(또는) 전염병 병원균의 증식에 대한 올리고뉴클레오티드 저해의 향상법(Enhancement of Oligonucleotide Inhibition of Protein Production, Cell Proliferation, and/or Multiplication of Infectious Disease Pathogens)
US5998193A (en) * 1994-06-24 1999-12-07 Gene Shears Pty., Ltd. Ribozymes with optimized hybridizing arms, stems, and loops, tRNA embedded ribozymes and compositions thereof
US5700923A (en) * 1994-09-29 1997-12-23 Hybridon, Inc. Finderons and methods of their preparation and use
US5650502A (en) * 1994-11-09 1997-07-22 Hybridon, Inc. Ribozyme analogs having rigid non-nucleotidic linkers
US5545729A (en) * 1994-12-22 1996-08-13 Hybridon, Inc. Stabilized ribozyme analogs
US20060182949A1 (en) * 2005-02-17 2006-08-17 3M Innovative Properties Company Surfacing and/or joining method

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3933384A1 (de) * 1989-10-06 1991-04-18 Hoechst Ag Multifunktionelle rna mit selbstprozessierungsaktivitaet, ihre herstellung und ihre verwendung

Also Published As

Publication number Publication date
CA2106015A1 (en) 1995-03-14
DE69302369D1 (de) 1996-05-30
ES2085767T3 (es) 1996-06-01
EP0625194A1 (de) 1994-11-23
CA2117428A1 (en) 1993-08-05
AU3597793A (en) 1993-09-01
AU661124B2 (en) 1995-07-13
EP0625194B1 (de) 1996-04-24
JPH07508638A (ja) 1995-09-28
DE69302369T2 (de) 1996-09-05
GR3019911T3 (en) 1996-08-31
WO1993015194A1 (en) 1993-08-05
DK0625194T3 (da) 1996-05-28

Similar Documents

Publication Publication Date Title
ES2065919T3 (es) Ribozimas.
DE69432934D1 (de) Oligonukleotidmodulation der expression von multiwirkstoff-resistenz -assoziiertem protein
ATE217904T1 (de) Nukleozyme
CY1110633T1 (el) Τροποποιηση αντιθετης φορας της εκφρασης σουρβιβινης
ATE154029T1 (de) 7-deazapurin modifizierte oligonukleotide
FR2715847B1 (fr) Composition contenant des acides nucléiques, préparation et utilisations.
DE69533697D1 (de) ANTISENSE OLIGONUKLEOTIDMODULATION DER raf GENEXPRESSION
EA199800943A1 (ru) Производные мочевины и их применение в качестве ингибиторов инозин-5`-монофосфат- дегидрогеназы
BG45042A3 (bg) Метод за получаване на ацилирани дикетонови съединения
BR9704344A (pt) Sistema de vários componentes para alterar degradar ou alvejar lignina materiais contendo lignina ou substâncias similares bem como processos para a sua aplicação
DE69634698D1 (de) Gewebespezifische und ziel-rna-spezifische ribozyme
EA199900632A1 (ru) 2-амино-6-(2-замещенные-4-фенокси)-замещенные-пиридины
DE69934998D1 (de) Antisense modulation der expression von integrin alpha 4
PT1053313E (pt) Oligonucleotidos ''antisense'' optimizados complementares de sequencias de dna metiltransferase
ATE137263T1 (de) Erhöhung der katalytischen aktivität von ribozymen mit einem benachbartem oligonukleotid als heffer
FI925210A7 (fi) Kokoonpanot ja menetelmät RNA-molekyylin aktiivisuuden moduloimiseksi RNA-molekyylin 5'-pään cap-rakenteen modifioimisella
EP1131107A4 (de) Antisense-modulation der expression von inhibitor-kappa-b-kinase-alpha
EP1163373A4 (de) Antisense-modulation des zellulären hemmstoffs der apoptosis-expression
EP1144690A4 (de) Antisense modulation der expression des zellulären hemmstoffs der apoptose-2
EA200401390A1 (ru) N-ацетилглюкозамин-6-фосфатдеацетилаза человека, взаимодействующая с каспазой-8, и способы ее применения
EA199901061A1 (ru) Новые соли врс-пептидов с органопротективной активностью, способ их получения и их использование в терапии
EP1066312A4 (de) Zirkuläre, haarnadelförmige, zirkulär/harnadelförmige, lassoförmige und haarnadel-lassoförmige "hammerhead" ribozyme
EP1173458A4 (de) Antinsens modulierung der sra expression
EP1373291A4 (de) Antisense-modulierung der recql4 expression
ES2062513T3 (es) Metodo para purificar estreptoquinasas.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee